Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP [NA]
A completed clinical trial evaluated the LMA Gastro dual-channel supraglottic airway device for oxygenation during ERCP procedures.
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of CT3001 in adults with advanced solid tumors is currently recruiting, including colorectal cancer and pancreatic ductal …
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers [Phase 1]
This document reports a Phase 1 clinical trial of NI-1801 for mesothelin-expressing solid cancers, with recruiting status and multiple indic…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery [Phase 3]
Phase 3 trial updates evaluate gemcitabine with or without erlotinib followed by the same regimen with or without radiation therapy and cape…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.
This clinical trial is profiling the intratumoral microbiome of pancreatic ductal adenocarcinoma using EUS-FNB tissue and exploring how micr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 ASCEND trial evaluating gemcitabine and nab-paclitaxel with LSTA1 (certepetide) versus placebo in untreated metastatic pancreatic du…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations
A clinical trial is actively recruiting to evaluate pancreatic cancer screening using elastase-1 detection in combination with other examina…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC
A clinical trial update suggests that combining AKR1B10 and CA19-9 improves the diagnosis of pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma [NA]
A clinical trial update from University Health Network evaluating high-resolution ultrasound in pancreatic ductal adenocarcinoma; the study …
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Innovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic Adenocarcinoma
A clinical trial is exploring innovative therapies to inhibit perineural invasion in pancreatic ductal adenocarcinoma and is not yet recruit…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 evaluation of NGM707 as a monotherapy and in combination with pembrolizumab in advanc…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Olaparib in Treating Patients With Stage IV Pancreatic Cancer [Phase 2]
This Phase 2 trial evaluated olaparib in patients with Stage IV pancreatic cancer, and results have been posted.
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001) [Phase 2]
Phase 2 trial ALTER-PA-001 is evaluating a combination of Anlotinib, Benmelstobart, and AG as first-line therapy for advanced metastatic pan…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: AB122 Platform Study [Phase 1]
Phase 1 AB122 platform study is currently recruiting for advanced or metastatic solid tumors, including pancreatic ductal adenocarcinoma and…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy [NA]
This clinical trial update describes ongoing enrollment for a study evaluating a standardized surveillance strategy to detect recurrent dise…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 trial of CEND-1 Injection (QLC12102) in advanced metastatic pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating CEND-1 in combination with chemotherapy as first-line therapy for pancreatic ductal adenocarcinoma is cu…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer [Phase 3]
A Phase 3 trial evaluating perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer [Phase 1]
This clinical trial update reports the Phase 1 study of CEND-1 in combination with nab-paclitaxel and gemcitabine for metastatic pancreatic …
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC [Phase 2]
Phase 2 clinical trial evaluating radiotherapy with sequential chemotherapy plus a PD-1 inhibitor and thymalfasin for borderline resectable …
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions [Phase 2]
Phase 2 study evaluating transabdominal ultrasound with BR55 to characterize pancreatic lesions in pancreatic ductal adenocarcinoma. The tri…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors [Phase 1, Phase 2]
Cantargia AB's CAN04 first-in-human study in solid malignant tumors (Phase 1/2) has completed. The trial encompassed several indications, in…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update on OT-101 in combination with mFOLFIRINOX for advanced, unresectable, or metastatic pancreatic ductal adenocarcinoma; …
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: The LINFU® U.S. Registry for the in the General Population Without Risk Factors
A clinical trial registry update from Adenocyte, LLC about the LINFU U.S. Registry; the study (NCT06276803) is not yet recruiting and involv…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors [Phase 2]
A Phase 2 trial evaluating Cediranib in combination with Olaparib in advanced solid tumors has posted results as of 2024-07-30. Indications …